サクティベル・バラスブラマニヤン

thumbnail image
サクティベル・バラスブラマニヤン
博士研究員
関連ウェブサイト
連絡先

bala atmark icredd.hokudai.ac.jp

SIDOROV, Pavel グループ
ジュニアPI
博士研究員

研究紹介

研究テーマ

Data analysis automation and predictive modeling

キーワード

De novo drug design, chemoinformatics, data analysis, machine learning

経歴

経歴書をご参照ください。

代表的な研究成果

  • Orally Bioavailable 4-Phenoxy-quinoline Compound as a Potent Aurora Kinase B Relocation Blocker for Cancer Treatment
    J. Li, T. Zhang, Q. Shi, G. Lv, X. Zhou, N. Choudhry, J. Kalashova, C. Yang, H.Li, Y. Long, S. Balasubramaniyan. ACS Pharmacol. Transl. Sci., 2023, 6, 1155–1163.
    DOI: 10.1021/acsptsci.3c00054
  • Virtually screened novel sulfathiazole derivatives as a potential drug candidate for methicillin-resistant Staphylococcus aureus and multidrug-resistant tuberculosis
    N. Saraswathy, S. Balasubramaniyan, N. Irfan. J. Biomol. Struct. Dyn., 2023, 41, 5086-5095.
    DOI: 10.1080/07391102.2022.2079002
  • Bioisosteric replacements of tyrosine kinases inhibitors to make potent and safe chemotherapy against malignant cells
    N. Irfan, S. Balasubramaniyan, D. Mubarak Ali, A. Puratchikody. J. Biomol. Struct. Dyn., 2022, 41, 9437-9447.
    DOI: 10.1080/07391102.2022.2146751
  • The synthesis and biological evaluation of virtually designed fluoroquinolone analogs against fluoroquinolone-resistant Escherichia coli intended for UTI treatment
    S. Balasubramaniyan, N.Irfan, C. Senthilkumar, A. Umamaheswari, A. Puratchikody. New J. Chem., 2020, 44, 13308-13318.
    DOI: 10.1039/D0NJ00657B
  • Design and virtual screening of novel fluoroquinolone analogs as effective mutant DNA GyrA inhibitors against urinary tract infection-causing fluoroquinolone resistant Escherichia coli
    S. Balasubramaniyan, N.Irfan, A. Umamaheswari, A. Puratchikody. RSC Adv., 2018, 8, 23629-23647.
    DOI : 10.1039/C8RA01854E